CSL
Search    
Include All CSL Behring Country Sites

Press Releases

11/12/2009
CSL Biotherapies obtains FDA licensure for use of its thimerosal-free pandemic Influenza A (H1N1) 2009 Monovalent Vaccine in children
CSL Biotherapies, a subsidiary of CSL Limited (ASX: CSL), one of the world's leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company's application for accelerated approval of its seasonal flu vaccine, Afluria® (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older. More.

09/16/2009
CSL Biotherapies Announces FDA Marketing Approval of its Monovalent Pandemic (H1N1) 2009 Influenza A Vaccine
CSL Biotherapies, a subsidiary of CSL Limited (ASX: CSL), one of the world’s leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental biologics licensing application for licensure of its monovalent pandemic (H1N1) 2009 influenza A vaccine for active immunization of persons age 18 years and older against influenza disease caused by the H1N1 virus. More.

09/10/2009
CSL Demonstrates Robust Immune Response from Single (15mcg) Dose of Monovalent Pandemic (H1N1) 2009 Influenza Vaccine in Healthy Adults
CSL Limited, Australia’s leading biopharmaceutical company, announced today that preliminary data from the first study of its candidate pandemic H1N1 vaccine demonstrated a robust immune response in healthy adults after a single unadjuvanted15mcg dose. More.

11/14/2008
Jesse Palmer Throws a "Season Pass" at Influenza Awareness to College Students Nationwide
To increase flu vaccination rates among college students, CSL Biotherapies is partnering on Season Pass© with Jesse Palmer, ESPN co-host of "College Football Live" and former pro football player. Season Pass is a novel program designed to immunize as many college students as possible during the 2008-2009 influenza (flu) season. College students are at risk for contracting the flu due to their close living quarters and frequent contact with other students. Season Pass aims to educate college students about influenza prevention and motivate them to visit their on-campus health center to get vaccinated. More.

10/16/2008
CSL Biotherapies Launches www.mercuryfreefluvaccine.com, An Online, Order-As-You-Go Service for Thimerosal-Free Influenza Vaccine
CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, today announced an innovative online quick-ship ordering system, enabling healthcare providers and other purchasers to buy CSL Biotherapies' thimerosal-free flu vaccine for adults directly from the company. This new purchasing platform (accessible at www.mercuryfreefluvaccine.com) offers customers enhanced access to a thimerosal-free product in the quantity they need, whenever they need it. More.

02/07/2006
CSL Limited to Apply for License to Market Influenza Vaccine in the U.S.
CSL Limited (ASX: CSL), a global, specialty biopharmaceutical company headquartered in Melbourne, Australia, today announced plans to introduce its influenza vaccine into the U.S. market. More.